tradingkey.logo

Advanced Biomed Inc

ADVB
0.284USD
-0.018-6.00%
收盘 02/02, 16:00美东报价延迟15分钟
6.14M总市值
亏损市盈率 TTM

Advanced Biomed Inc

0.284
-0.018-6.00%

关于 Advanced Biomed Inc 公司

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc简介

公司代码ADVB
公司名称Advanced Biomed Inc
上市日期Mar 06, 2025
CEO- -
员工数量31
证券类型Ordinary Share
年结日Mar 06
公司地址401 Ryland St
城市RENO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编89502
电话1862120510823
网址http://www.advanbiomed.com/
公司代码ADVB
上市日期Mar 06, 2025
CEO- -

Advanced Biomed Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月1日 周日
更新时间: 2月1日 周日
持股股东
股东类型
持股股东
持股股东
占比
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
其他
30.58%
持股股东
持股股东
占比
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
其他
30.58%
股东类型
持股股东
占比
Individual Investor
59.33%
Corporation
10.09%
Hedge Fund
0.64%
Venture Capital
0.24%
Investment Advisor
0.18%
Research Firm
0.15%
其他
29.36%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
6
262.83K
0.61%
--
2025Q3
6
262.83K
0.61%
+131.46K
2025Q2
4
131.38K
0.05%
+120.16K
2025Q1
1
11.21K
0.00%
+11.21K

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Lu (Yi Ph.D.)
6.71M
31%
--
--
Jul 23, 2025
Pau (Hung To)
3.52M
16.29%
--
--
Jul 23, 2025
Advance on Ventures Ltd
2.18M
10.09%
--
--
Jul 23, 2025
Luo (Xiaoyuan)
1.40M
6.46%
--
--
Jul 23, 2025
Citadel Advisors LLC
139.51K
0.64%
+81.84K
+141.92%
Sep 30, 2025
XTX Markets LLC
52.23K
0.24%
+52.23K
--
Sep 30, 2025
HRT Financial LP
35.68K
0.16%
+35.68K
--
Sep 30, 2025
Virtu Americas LLC
32.05K
0.15%
+7.77K
+32.00%
Sep 30, 2025
UBS Financial Services, Inc.
3.36K
0.02%
-21.47K
-86.47%
Sep 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI